Sign in
4

Changes in Ownership

Corbus Pharmaceuticals Holdings, Inc. Filed Acc 0001209191-22-045137

Chief Financial Officer bought 20,000 shares at $0.26 ($5,198)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Moran Sean F. Chief Financial Officer 2022-08-10 Purchase +20,000 $0.26 $5,198 199,272 D: show line 1 in the form
Open-market purchases · 20,000 sh · avg $0.26 · $5,198
Loading xslF345X03/doc4.xml…